Page 3 - Nasdaq Tyra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq tyra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Tyra Today - Breaking & Trending Today

Tyra Biosciences (NASDAQ:TYRA) Shares Down 2.3% Following Insider Selling

Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report)’s share price dropped 2.3% during trading on Monday following insider selling activity. The company traded as low as $16.30 and last traded at $16.63. Approximately 9,285 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 58,293 shares. The stock had previously […] ....

United States , Tyra Biosciences , Todd Harris , Daniel Bensen , Deutsche Bank , Tyra Biosciences Inc , America Corp , Sorce Advisory , Securities Exchange Commission , Tyra Biosciences Company Profile , Free Report , Exchange Commission , Biosciences Stock Down , Rhumbline Advisers , Tyra Biosciences Daily , Nasdaq Tyra ,

Tyra Biosciences, Inc. (NASDAQ:TYRA) CEO Todd Harris Sells 1,300 Shares

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) CEO Todd Harris sold 1,300 shares of the business’s stock in a transaction on Tuesday, June 20th. The stock was sold at an average price of $16.53, for a total value of $21,489.00. Following the completion of the sale, the chief executive officer now directly owns 1,645,222 shares […] ....

Todd Harris , Tyra Biosciences , Tyra Biosciences Inc , Barclays Plc , Tyra Biosciences Company Profile , Securities Exchange Commission , Charles Schwab Investment Management Inc , Get Rating , Exchange Commission , Schwab Investment Management , Tyra Biosciences Daily , Nasdaq Tyra , Insider Trading , Nsider Trades ,

Todd Harris Sells 12,773 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) Stock

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) CEO Todd Harris sold 12,773 shares of the stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $16.13, for a total value of $206,028.49. Following the sale, the chief executive officer now owns 1,701,276 shares of the company’s […] ....

Todd Harris , Tyra Biosciences , Sorce Advisory , Geode Capital Management , Tyra Biosciences Inc , Get Rating , Street Corp , Capital Management , Artia Global Partners , Tyra Biosciences Daily , Nasdaq Tyra , Insider Trading , Nsider Trades ,

Tyra Biosciences, Inc. (NASDAQ:TYRA) CEO Sells $126,832.00 in Stock

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) CEO Todd Harris sold 7,927 shares of the company’s stock in a transaction on Tuesday, June 13th. The stock was sold at an average price of $16.00, for a total transaction of $126,832.00. Following the completion of the transaction, the chief executive officer now owns 1,701,276 shares of […] ....

Todd Harris , Tyra Biosciences , Securities Exchange Commission , Barclays Plc , Charles Schwab Investment Management Inc , Tyra Biosciences Inc , Get Rating , Exchange Commission , Schwab Investment Management , Tyra Biosciences Daily , Nasdaq Tyra , Insider Trading , Nsider Trades ,

Todd Harris Sells 7,927 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) Stock

Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Rating) CEO Todd Harris sold 7,927 shares of the stock in a transaction that occurred on Tuesday, June 13th. The shares were sold at an average price of $16.00, for a total transaction of $126,832.00. Following the sale, the chief executive officer now owns 1,701,276 shares in the company, […] ....

Tyra Biosciences , Todd Harris , Deutsche Bank , Barclays Plc , Tyra Biosciences Inc , Securities Exchange Commission , Get Rating , Exchange Commission , Tyra Biosciences Daily , Nasdaq Tyra , Insider Trading , Nsider Trades ,